2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mete, A | 2 |
Bowers, K | 2 |
Chevalier, E | 1 |
Donald, DK | 2 |
Edwards, H | 1 |
Escott, KJ | 2 |
Ford, R | 2 |
Grime, K | 2 |
Millichip, I | 1 |
Teobald, B | 1 |
Russell, V | 2 |
Bull, RJ | 1 |
Coope, H | 1 |
Mather, A | 1 |
Ray, NC | 1 |
2 other studies available for 2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
The discovery of AZD9164, a novel muscarinic M3 antagonist.
Topics: Blood Proteins; Drug Evaluation, Preclinical; Humans; Muscarinic Antagonists; Piperidines; Protein B | 2011 |
The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.
Topics: Administration, Inhalation; Animals; Bronchoconstriction; Cycloheptanes; Disease Models, Animal; Gui | 2013 |